Downregulation of nucleoporin 88 and 214 induced by oridonin may protect OCIM2 acute erythroleukemia cells from apoptosis through regulation of nucleocytoplasmic transport of NF-κB.

Oridonin has been utilized for the treatment of various human diseases due to its anti-inflammatory, antibacterial and antitumor effects. However, the precise mechanisms induced by oridonin in human erythroleukemia are yet to be clarified. The present study aimed to elucidate possible oridonin-induced apoptotic mechanisms in OCIM2 cells, as well as the possible mechanisms whereby OCIM2 cells are relatively resistant to oridonin. Results in the present study showed that oridonin significantly inhibited OCIM2 and OCI-AML3 cell proliferation in a dose- and time-dependent manner, while expressing a much higher IC50 in OCIM2, compared to OCI-AML3. These results also indicated that oridonin induced OCIM2 cell apoptosis, associated with p65 and Bax, while activating caspases-9, -6 and -3. However, p65 was only partly translocated into the nucleus, while most of the p65 was retained in the cytoplasm. Moreover, nucleoporin 214 (Nup214) and nucleoporin 88 (Nup88) were downregulated at the transcriptional and protein levels, subsequent to oridonin treatment. Taken together, these data suggest that oridonin has the potential to induce OCIM2 cell-apoptosis, involving NF-κB activation, whereas the downregulation of Nup88 and Nup214 may protect OCIM2 through the regulation of the nucleocytoplasmic transport of p65.

Citation

Sha Yi, Yan Chen, Lu Wen, Lijing Yang, Guohui Cui. Downregulation of nucleoporin 88 and 214 induced by oridonin may protect OCIM2 acute erythroleukemia cells from apoptosis through regulation of nucleocytoplasmic transport of NF-κB. International journal of molecular medicine. 2012 Oct;30(4):877-83

Mesh Tags

Substances

PMID: 22824908

search → result